Search Results
Mar 09, 2026, 19:59 ET ALIT Investor News: If You Have Suffered Losses in Alight, Inc. (NYSE: ALIT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alight, Inc. (NYSE: ALIT) resulting from allegations that Alight may have issued materially misleading business information to the investing public.So What: If you purchased
More news about: THE ROSEN LAW FIRM, P. A.
Mar 05, 2026, 17:11 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alight, Inc. - ALIT
March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alight, Inc. ("Alight" or the "Company") (NYSE: ALIT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Mar 04, 2026, 14:15 ET ALIT: ADJUSTED EBITDA vs. GAAP FIGURES DIVERGED SHARPLY -- LEVI & KORSINSKY, LLP INVESTIGATES
StoryNEW YORK, March 4, 2026 /PRNewswire/ -- Alight, Inc. (NYSE: ALIT) shareholders lost money after Q4 2025 results revealed a significant gap between the adjusted financial metrics management had emphasized and the Company's
More news about: Levi & Korsinsky, LLP
Mar 03, 2026, 16:29 ET Rosen Law Firm Encourages Alight, Inc. Investors to Inquire About Securities Class Action Investigation - ALIT
Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alight, Inc. (NYSE: ALIT) resulting from allegations that Alight may have issued materially misleading business information to the investing public.So What: If you purchased
More news about: THE ROSEN LAW FIRM, P. A.
Feb 26, 2026, 15:18 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alight, Inc. - ALIT
Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alight, Inc. ("Alight" or the "Company") (NYSE: ALIT). Such investors are advised to contact Danielle Peyton at [email protected] or
More news about: Pomerantz LLP
Feb 03, 2026, 08:45 ET OnePack Plan by PetPartners to Offer Seamless Pet Insurance Access with Alight
OnePack Plan by PetPartners, an employer-based pet insurance provider, and Alight, Inc. (NYSE: ALIT), a leading cloud-based human capital and technology-enabled services provider, today announced a new partnership that enables Alight clients to easily
More news about: OnePack Plan by PetPartners
Nov 12, 2025, 08:45 ET Theranica's Nerivio® REN Wearable Featured in Headache for Delivering Effective, Consistent Drug-Free Relief in Migraine Over Three Years
"The publication of this multi-year, month-by-month, real-world evidence study in Headache marks a watershed moment in migraine care," said Alit Stark-Inbar, corporate vice president of medical information and research at Theranica. "The results show that REN therapy provides consistent, long-term
More news about: Theranica
Oct 28, 2025, 08:45 ET Theranica's Nerivio® REN Wearable Validated in Landmark 55,000-Patient Study Published in Cephalalgia
and reducing the overall burden of migraine, including the impact on quality of life, medication overuse headache, and disease chronification," said Alit Stark-Inbar, PhD, Vice President of Medical Information and Research at Theranica. "Moreover, timely intervention is expected to increase treatment
More news about: Theranica
Oct 08, 2025, 14:48 ET Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence
invasive procedures. "We are excited to engage with the pediatric neurology community at this year's CNS Annual Meeting," said Alit Stark-Inbar, VP of Medical Information and Research at Theranica. "Through our product theater and new real-world evidence studies, we look forward
More news about: Theranica